Bill Sponsors: NJ A1136 | 2022-2023 | Regular Session

Bill Title: Requires physician to offer to test patient for dihydropyrimidine dehydrogenase deficiency prior to patient undergoing chemotherapy.

Spectrum: Partisan Bill (Republican 2-0)

Status: (Introduced - Dead) 2022-01-11 - Introduced, Referred to Assembly Health Committee [A1136 Detail]

Text: Latest bill text (Introduced) [HTML]

Sponsors

NameTypeSponsorshipDistrictFinancialEncyclopediaBiography
Representative Christopher DePhillips [R]PrimarySponsored BillsHD-040FollowTheMoneyBallotpediaVoteSmart
Representative Kevin Rooney [R]PrimarySponsored BillsHD-040FollowTheMoneyBallotpediaVoteSmart

Social Comments on NJ A1136

feedback